WXXWY:OTCMKTS
Wuxi Biologics Cayman ADR
12,56 US$
arrow_upward
+0,48%(+0,060) 1 Д
16. окт, 16:00:00 GMT-4 · USD
search
Сви симболи
| Симбол | Цена | Промена | % промене |
|---|
insights_autoГенеришу се најзначајнији увиди за WXXWY...
Отвори
12,29 US$
Високо
12,56 US$
Ниско
12,20 US$
Трж. капитализација
198,43 млрд.
Прос. количина
61,89 хиљ.
Количина
110,85 хиљ.
Највиша у 52 недеље
14,80 US$
Најнижа у 52 недеље
7,30 US$
Бета
0,01
Акцијски капитал
2,06 млрд.
Бр. запослених
15 хиљ.
Отвори
12,29 US$
Високо
12,56 US$
Ниско
12,20 US$
Трж. капитализација
198,43 млрд.
Прос. количина
61,89 хиљ.
Количина
110,85 хиљ.
Највиша у 52 недеље
14,80 US$
Најнижа у 52 недеље
7,30 US$
Бета
0,01
Акцијски капитал
2,06 млрд.
Бр. запослених
15 хиљ.
Вести
Из веб-извора и од партнера за вести
BizPortal.rs
·
пре 1 дана
Američki berzanski indeksi u padu - S&P 500 je oslabio 0,5, Nasdak 1,3 odsto
Detroit Free Press
·
пре 13 минута
Memory-chip rout, inflation, CoreWeave: The week on Wall Street
Yahoo Finance
·
пре 45 минута
Missing the S&P 500's 10 Best Days in 20 Years Cut a $10,000 Investment's Ending Value by More Than Half
Профил
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Wuxi Biologics Cayman ADR – основни подаци
Главни извршни директорЧжишенг Чен
Запослени14,7 хиљ.
Основано2010
Седиште-
Сектор-
Веб-сајтwuxibiologics.com